English
简体中文
Total: £ 56.28
2025-09-20 | Pages: 99 | Tables: 102
The global market for NK-1 Receptor Antagonists was valued at US$ 805 million in the year 2024 and is projected to reach a revised size of US$ 1266 million by 2031, growing at a CAGR of 6.8% during the forecast period.The 2025 U.S. tariff policies in...
2025-09-18 | Pages: 79 | Tables: 76
The global Superoxide Dismutase market size was US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 117 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to i...
2025-09-18 | Pages: 111 | Tables: 115
The global Parenteral Nutrition market size was US$ 4327 million in 2024 and is forecast to a readjusted size of US$ 6060 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to ...
2025-09-18 | Pages: 76 | Tables: 76
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market size was US$ 890 million in 2024 and is forecast to a readjusted size of US$ 9573 million by 2031 with a CAGR of 41.0% during the forecast period 2025-2031. By 2025, the evolving U.S. ...
2025-09-18 | Pages: 76 | Tables: 79
The global Human Vaccine Adjuvants market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to inject cons...
2025-09-18 | Pages: 98 | Tables: 93
The global Ursodeoxycholic Acid market size was US$ 583 million in 2024 and is forecast to a readjusted size of US$ 995 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to in...
2025-09-18 | Pages: 100 | Tables: 91
The global Electrolyte Tablet market size was US$ 741 million in 2024 and is forecast to a readjusted size of US$ 5722 million by 2031 with a CAGR of 34.4% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to in...
2025-09-18 | Pages: 91 | Tables: 91
The global Circadian Rhythm Sleep Treatment market size was US$ 925 million in 2024 and is forecast to a readjusted size of US$ 1427 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.Circadian rhythm disorders are disruptions i...
2025-09-18 | Pages: 78 | Tables: 76
The global Bowel Preparation Drugs market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to inject cons...
2025-09-18 | Pages: 73 | Tables: 65
The global Prothrombin Complex Concentrate (PCC) Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is po...
2025-09-18 | Pages: 100 | Tables: 95
The global market for Topical Antibiotic Drug was valued at US$ 10242 million in the year 2024 and is projected to reach a revised size of US$ 12976 million by 2031, growing at a CAGR of 3.2% during the forecast period.Topical antibiotic drugs refer ...
2025-09-18 | Pages: 93 | Tables: 97
The global market for Powder for Inhalation was valued at US$ 13670 million in the year 2024 and is projected to reach a revised size of US$ 18628 million by 2031, growing at a CAGR of 4.6% during the forecast period.The 2025 U.S. tariff policies int...
2025-09-18 | Pages: 118 | Tables: 114
The global market for Pain Therapeutic Solutions was valued at US$ 77860 million in the year 2024 and is projected to reach a revised size of US$ 103427 million by 2031, growing at a CAGR of 4.2% during the forecast period.Pain Therapeutic Solutions ...
2025-09-18 | Pages: 104 | Tables: 104
The global market for PDE-3 Inhibitors was valued at US$ 656 million in the year 2024 and is projected to reach a revised size of US$ 899 million by 2031, growing at a CAGR of 4.7% during the forecast period.The 2025 U.S. tariff policies introduce pr...
2025-09-18 | Pages: 69 | Tables: 75
The global market for Multiple Myeloma Monoclonal Antibody Drugs was valued at US$ 1251 million in the year 2024 and is projected to reach a revised size of US$ 2030 million by 2031, growing at a CAGR of 7.1% during the forecast period.The 2025 U.S. ...
